Objective The Japan Diabetes Society (JDS) has recommended target levels of glycemic control based on guidelines for the management of diabetes mellitus (DM). The Japan Society of Ningen Dock created a database of subjects receiving annual health examinations nationwide. Using this database, we evaluated the efficacy of current treatment for patients with DM based on the JDS recommendations. Methods This multicenter, retrospective study was conducted using data obtained from 21 institutions across Japan. In order to assess the level of glycemic control in the Japanese population, we analyzed previously obtained measurements of HbA1c in 7,180 patients 20 to 79 years of age (mean age: 57.9±8.7 years, 6,007 men and 1,173 women) taking DM medications. Results According to the JDS guidelines, 44.7% of the patients fell into the good glycemic control group, with an HbA1c level of <7.0% while 22.4% were classified into the poor glycemic control group, with an HbA1c level of ! 8.0%. The control of other arteriosclerosis risk factors deteriorated as the glycemic control deteriorated. Lifestyle factors were strongly found to be associated with glycemic control in the patients receiving DM treatment. Conclusion Aggressive lifestyle modification is needed to improve glycemic control in patients with DM.
Introduction
The increasing prevalence of diabetes mellitus (DM) and its complications is a major public health problem worldwide. The number of patients with DM in Japan is increasing. A recent national survey showed that the number of patients with probable DM increased from 6.9 to 8.9 million between 1997 and 2007, while the number of patients with probable impaired glucose tolerance (IGT) increased from 6.8 to 13.2 million (1). The prevalence of DM and IGT in adults more than 40 years of age is approximately 30% (1) . These patients have significantly higher risks of DM complications if adequate medical care and patient education are not provided.
The effectiveness of medical care provided to DM patients can be estimated based on outcome studies analyzing the level of glucose control. Such outcome studies are necessary to determine the present status of DM medical care and the future incidence of DM complications. Recent surveys have shown that the medical care provided to Japanese patients with DM is comparable to or slightly better than that observed in other countries (2, 3) . The Japan Diabetes Society (JDS) has published reports regarding the diagnostic criteria for DM (4) (5) (6) (7) . The JDS changed the expression of HbA1c from the JDS value to the National Glycohemoglobin Standardization Program (NGSP) value in April 2012 (8) and set a target level of HbA1c <7.0 % for glycemic control required to prevent complications in 2003 (9, 10) . The present status of glycemic control in Japanese patients with DM is an important public health concern.
Hence, we aimed to assess the effectiveness of DM care provided by general practitioners in Japan.
Materials and Methods

Study design
This cross-sectional, observational study assessed the rates of achieving the target level of glycemic control based on the JDS guidelines (9) .
Study population
This multicenter, retrospective study was conducted using data for 287,342 subjects undergoing annual health examinations in 2009 at 21 Ningen Dock institutes located throughout Japan (11) (12) (13) . The level of quality control among the participating institutions was irrelevant, as all institutes passed the functional evaluation test for health examination facilities conducted by the Japan Society of Ningen Dock. Among the 268,931 subjects 20 to 79 years of age, there were 8,067 patients (3.0%) taking DM medications. We excluded those with missing data (e.g., data regarding medications, lifestyle habits, etc.). Therefore, 7,180 subjects under DM treatment were included in the final study.
This study was designed in compliance with the ethics regulations outlined in the Declaration of Helsinki. Anonymized health records were used for the analysis, and the privacy of the participants was completely protected. This study was approved by the ethics committee of the Japan Society of Ningen Dock.
Methods
Anthropometric measurements and blood samples were obtained after overnight fasting. Weight and height were measured using standardized techniques and equipment. The HbA1c levels were measured according to a latex agglutination method or high-performance liquid chromatography in each clinic or hospital. The HbA1c level was estimated as the NGSP equivalent value calculated using the following formula: HbA1c (%) = HbA1c (JDS; %) + 0.4 (8) . The serum low-density lipoprotein (LDL)-cholesterol (LDL-C) level was calculated using the Friedewald formula (14) and measured using a direct homogeneous assay when the triglyceride (TG) level was ! 400 mg/dL.
In order to assess the degree of glycemic control, we used the current local guideline targets: HbA1c <7%, blood pressure (BP) <130/80 mmHg, LDL-C <120 mg/dL, highdensity lipoprotein (HDL)-C ! 40 mg/dL, TG <150 mg/ dL (8-10) and body mass index (BMI) <25 kg/m 2 (15) . Lifestyle recommendations were based on a questionnaire developed for use in specific health examinations and health guidance (16) composed of nine health-related behavioral recommendations, including items such as smoking, physical activity, dietary habits, and alcohol consumption.
The comparisons of the mean levels of HbA1c were made using either the t-test or analysis of variance (ANOVA) followed by Scheffe's multiple comparison test. The chisquared test was used to compare differences in the proportion of men and women. The Mantel-extension method was used as a trend test. All statistical analyses were carried out using the SAS Version 9.3 software program (SAS Institute Inc., Cary, USA). A p-value of <0.05 was considered to be statistically significant. All results are expressed as the mean ± SD. Table 1 shows the characteristics of the study patients. The mean age of the patients was 57.9±8.7 years, with the majority (62.5%) of subjects between 50 and 64 years of age. The percentage of men was 83.7%. The overall mean HbA1c level among these patients was 7.3±1.2%. The mean BMI was 25.0 kg/m 2 , with 44.1% of the patients exceeding the Japanese criteria for obesity (BMI ! 25 kg/m 2 ) (15). The mean fasting plasma glucose (FPG), BMI, waist circumference (WC), diastolic BP, and TG values in men were higher than those observed in women. In contrast, age and the total cholesterol (TC), LDL-C and HDL-C levels in women were higher than those observed in men. Overall, men had more undesirable lifestyle factors than women. Approximately half of the patients met the JDS guidelines for a BP of <130/80 mmHg (10) . Over 50% of patients met the JDS guidelines for an LDL-C level of <120 mg/dL, HDL-C level of ! 40 mg/dL and TG level of <150 mg/dL (10) .
Results
As per the JDS guidelines, an HbA1c level of <7.0% represented good glycemic control, with 44.7% of the patients exhibiting good glycemic control. In contrast, an HbA1c level of ! 8.0% represented poor glycemic control, with 22.4% of the patients exhibiting poor glycemic control (Figure) . There were no significant differences in the glycemic control status according to sex. When stratified by age, the elderly subjects showed better glycemic control. Table 2 presents the laboratory data and undesirable lifestyle habits of the patients according to the three groups of glycemic control. There were no differences in the percentage of women among the groups. The average age was significantly lower in the poor glycemic control group. The mean levels of FPG, HbA1c, WC, TC, LDL-C and TG were significantly higher, while the HDL-C levels were significantly lower, in the poor glycemic control group, followed by the fair glycemic control group and the poor glycemic control group. The mean values of BMI, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly higher in the poor glycemic control group. In addition to glycemic control, the prevention of diabetes mellitus (DM) complications requires the control of other parameters. Table 2 shows the data relating to these complications, including BP and the lipid levels. A positive correlation was found between the deterioration of glycemic control and the deterioration of other atherosclerotic risk factors. The percentage of patients taking medications for hypertension and dyslipidemia was decreased in the DM patients with poor glycemic control. The undesirable lifestyle habits of the three groups according to glycemic control are presented in Table 2 . For smoking, exercise habits, dietary habits and alcohol consumption, the percentage of undesirable lifestyle factors, except for alcohol consumption, were significantly higher in the fair glycemic control group and poor glycemic control group than in the good control group. Furthermore, a trend was observed in which deterioration of all lifestyle habits except alcohol consumption was associated with a higher HbA1c level. In contrast, the comparison of the amount of alcohol consumption revealed no differences in the percentages of subjects who drank ! 75 g/day. 
Discussion
The average HbA1c level in our study population was 7.3%. The average HbA1c levels in other countries have been reported to range from 7.5% to 8.6% (17) (18) (19) (20) (21) (22) (23) (24) (25) . However, glycemic control in Asian patients with DM is generally poor (23) (24) (25) , whereas the average level of glycemic control in Japan is fair (2, 3) . One study (2) reported that the mean HbA1c level in 16,934 Japanese patients with DM in 2002 was 7.5%, while another study (3) showed that the mean HbA1c level in 15,652 Japanese DM patients in 2006 was 7.2%. The status of glycemic control in DM patients in this study was very similar to that observed in other largescale studies in Japan. Therefore, the level of glycemic control in Japan is slightly better than that noted in other countries. One possible reason for the better HbA1c control observed in Japan may be our medical care system. Patients are free to choose and have access to any clinic or hospital. Moreover, Japanese medical insurance covers all people who live in Japan and is guaranteed to pay at least 70% of medical fees. This allows patients to visit clinics or hospitals for examinations of the HbA1c levels or other laboratory tests and to receive medications. The percentage of DM patients under medication in this study was 3.0%, which is slightly less than the rate of 5.2% reported in a national survey (1). This suggests that fewer DM patients under medication receive annual health examinations, likely due to the need for frequent blood tests.
In the present study, the control of other arteriosclerosis risk factors deteriorated as the level of glycemic control deteriorated. To our knowledge, this is the first large-scale study to evaluate the rate of achievement of treatment goals for obesity, blood pressure and the lipid levels in Japan. The percentage of subjects taking medications for hypertension and dyslipidemia was decreased among those whose blood sugar was poorly controlled. Furthermore, the DM patients with poor glycemic control showed poorly controlled blood pressure and lipid levels regardless of treatment (medication or non-medication). The frequency of undesirable lifestyle factors, except for alcohol consumption, was significantly higher in the fair and poor glycemic control groups than in the good control group. In a Korean study, DM patients who adhered to ! 5 of the 10 lifestyle recommendations had better blood lipid levels and improved glycemic control than those who did not (26) . Our findings support the results of previous studies, in that lifestyle habits were found to be strongly associated with glycemic control in the patient under treatment for DM. The JDS guidelines suggest that that prohibition of alcohol intake is not always necessary in patients with good glycemic control and no complications or liver disease. The recommendation may be associated with a higher frequency of drinking in subjects with good glycemic control. Since the status of glycemic control in the DM patients showed no correlation with the percentage of DM patients who drank ! 75 g/day, the results suggest that the DM patients evaluated in this study had more drinking opportunities, although they rarely drank ! 75 g/day.
The evaluation of glycemic control among younger subjects in this study was not satisfactory due to the limited number of patients <40 years of age, accounting for less than 2% of the total population. It is likely that a large percentage of subjects receiving annual health examinations are economically blessed and interested in their health. It is also uncertain whether all subjects under medication were diagnosed with DM, as those taking voglibose due to impaired glucose tolerance may have been included in this study. Subjects under diet or exercise therapy without medication were not included in this study. Other limitations of this study include the following: 1) the type of DM was not assessed, 2) the DM treatment was not evaluated in detail, 3) the relationship of cause and effect cannot be ascertained due to the cross-sectional design of the study.
This study investigated the rate of achievement of target goals among patients with DM receiving medications who underwent annual health examinations at nationwide institutes. Over the half of the patients with DM continued to exhibit an HbA1c levels of ! 7.0%; therefore aggressive lifestyle modification is needed to improve glycemic control in such patients.
The authors state that they have no Conflict of Interest (COI).
